February 2nd, 2012
The Biggest Opportunities for Cost Savings in Cardiology: Take II
In response to my recent post, we received some nice suggestions about where to eliminate waste in cardiovascular care. There were also some interesting concerns. We welcome more. Here are the suggestions that stood out:
- Seek to optimize medical therapy over stenting for some patients.
- More judicious use of imaging with stress tests.
- Avoid using biomarkers for ACS in circumstances where they are highly unlikely to modify your approach.
Let’s work with these suggestions. Since clinical decisions are made case by case — and each situation has its own nuance — how do we move the needle to decrease testing and treatment that does not provide any benefit? Can we become more specific about where there are opportunities? How would it work best? What would our community suggest?
And surely you have additional suggestions for areas where we can use fewer resources without compromising the care of patients (or even to improve it). Consider this a suggestion box for cardiology. Please share!
Comments are closed on this post, but please join the conversation at our news story on the ACC’s and the American Society of Nuclear Cardiology’s contributions to the Choosing Wisely initiative.